Roberto Chiesa, PhD

Location: 

Laboratory of Prion Neurobiology, Department of Neuroscience, Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy

Grant Year: 

2019


Dr. Chiesa has identified a porphyrin that has two potentially synergic anti-prion properties: it down-regulates PrPC, thus depleting the substrate for prion formation, and inhibits PrPSc replication in in vitro and ex vivo models. The aims of the project are: 1) to use nanoparticles engineered to cross the blood-brain barrier to efficiently deliver this compound to the brain; and 2) to carry out efficacy tests in prion-infected mice.

To learn more about Dr. Chiesa's previous CJD Foundation Research Grant, click here.

Dr. Chiesa is the recipient of: